Wealth Management, OTC Product Development Lead - Vice President

JPMorgan Chase & Co.•New York, NY

68d•$122,550 - $201,000•Onsite

About The Position

J.P. Morgan Private Bank is looking for a Vice President to join our New York-based US Derivatives Product Development team. We own the global OTC and structured products journeys end to end, partnering with Sales, CIB, Technology and Operations to automate and scale distribution, deliver seamless client experience, and embed robust risk globally. As a OTC Product Development Lead, Vice President, you will be the architect of the end-to-end product journey for the US and Latam Private Bank. You are the single point of accountability for bridging the gap between our Sales teams, broader stakeholders and the Corporate & Investment Bank (CIB). Your goal is to transform complex OTC products into a seamless, automated, and scalable client experience, ensuring the US lead sets a very high standard that aligns with our global business.

Requirements

Minimum 6 years experience in Product Development or Digital Markets with a proven track record of front-to-back delivery.
Deep derivatives technical fluency across Equities, FX, Rates, Credit, and Commodities, including a solid grasp of xVA and lifecycle events.
Experience delivering integrations and platform scalability within a highly regulated environment.
A self-driven owner who isn’t afraid to challenge and who prioritizes high-impact delivery.
Exceptional stakeholder management skills with the ability to translate complex data into "board-ready" governance materials and business strategies.

Responsibilities

Lead high-level relationships across the Private Bank stakeholders and CIB market teams. Align stakeholders across Legal, Risk, Compliance, and Tech to turn complex product journeys into simplified realities.
Define and execute the OTC product strategy. This includes managing the commercial lifecycle, pre and post trade experiences, and marketing while securing all necessary governance approvals.
Drive deep integration with CIB platforms. Champion "first-time-right" execution by embedding suitability mapping and automation directly into the order workflow.
Lead the automation of quoting, booking, and collateral management, using data to reduce cycle times and eliminate manual errors.
Enhance risk and credit frameworks. Deliver superior portfolio-level risk analytics and collateral visibility for both the bank and our clients.
Act as the primary lead for regulatory implementations, ensuring all OTC products meet evolving global standards and audit requirements.
Innovate product development to include analyzing the trade flow journey from onboarding to trade lifecycle. Driving platform adoption, marketing , enhance capabilities and obtaining any governance approvals.
Identify, evaluate and implement strategic enhancements to the business through automation, vendor relationships or other means for business change.
Drive measurable revenue uplift through scaled distribution and increased usage of click to trade capabilities.
Ensure a unified, "one-bank" client journey across the US, EMEA, and Asia.
Maintain a proactive control environment where pre-trade checks and suitability are non-negotiable gatekeepers for every launch.